Kazakhstan unveils freeze drying tech for 50 year food storage
Kazakh scientists develop freeze-drying unit for 50-year food storage, clean hydrogen reactor, and anti-cancer drug under trials
ASTANA, Kazakhstan (MNTV) — In a wave of scientific breakthroughs, researchers in Kazakhstan have introduced new technologies that could transform agriculture, energy, and medicine in the country.
According to a report by The Times of Central Asia, scientists at Al-Farabi Kazakh National University have developed a mobile freeze-drying unit called “Dayar 20,” designed to preserve agricultural products for up to 50 years. The unit can be transported directly to orchards and farms, making it especially useful in remote areas.
The core of the innovation lies in lyophilization—removing water from frozen food via evaporation under low pressure. Project lead Yerbol Ikhsanov, a PhD in chemistry, said the technique allows the food to retain its shape, taste, aroma, color, and vitamins. “Products dried using the Dayar 20 unit remain usable for a long time,” he said.
Capable of processing fruits, vegetables, meat, dairy, and ready-to-eat meals, the system allows shelf lives ranging from three years at room temperature to as long as 50 years when vacuum-sealed. The invention is expected to bolster Kazakhstan’s food security and agricultural export capabilities.
Meanwhile, at the Institute of Combustion Problems, scientists have created a low-energy plasma reactor that produces hydrogen and carbon from hydrocarbon gases—without using any catalysts.
The gases are heated to temperatures between 1,800°C and 2,700°C, causing pyrolysis and generating hydrogen with a purity of up to 98.9%.
Researchers also discovered an unexpected by-product: giant carbon nanotubes up to 100 nanometers in diameter. These materials hold potential for developing ultra-strong composites, making this a dual breakthrough in clean energy and advanced materials.
In another milestone, Kazakh scientists are advancing clinical trials for a new anti-cancer drug. Dos Sarbasov, Vice President of the National Academy of Sciences, revealed that the drug halted tumor growth in six patients and reduced tumor size by 30% in one case. “After the first dose, the condition of 15 cancer patients stabilized,” Sarbasov said.
The drug specifically targets cells with high glucose absorption and has shown no toxicity so far. It is undergoing trials at the Kazakh Institute of Oncology and Radiology and is expected to complete testing within two to three years. The formula has already been granted international patent protection.
Have Your Say!
Have you been affected by the issues raised in this story? Please share your experiences by emailing haveyoursay@soundvision.com.
Please include a contact number if you are willing to speak to a Muslim Network TV’s representative. You can also get in touch in the following ways:
Tweet: @MuslimNetworkTV
We must take charge of our narrative. Research indicates that 92% of their Muslim coverage is negative. Help us change that.
